Antares Vision Group has launched DIAMIND Sentry, a solution designed to allow pharma companies to efficiently manage the substantial uptick in exceptions stemming from traceability mandates. The system was developed by rfxcel, a business unit of Antares providing supply chain visibility solutions. The implementation of widespread traceability regulations, notably the FDA’s Drug Supply Chain Security Act (DSCSA), requires the electronic exchange of unit-level product data, amplifying the vol...